BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Topigen Pharmaceuticals Inc. Initiates Expanded Phase II Trial of Inhaled TPI ASM8 in Patients With Asthma

  March 8, 2007

   · 

  1 min read
• Business

  MethylGene Reports Year-End 2006 Financial Results

  March 8, 2007

   · 

  1 min read
• FDA

  Barrier Therapeutics, Inc. Receives Regulatory Approval to Market Xolegel(TM) in Canada

  March 8, 2007

   · 

  1 min read
• Drug Development

  Myriad Genetics, Inc. Initiates Phase 2 Clinical Trial of Azixa(TM) in Brain Cancer

  March 8, 2007

   · 

  1 min read
• Drug Development

  Resverlogix Corporation RVX-208 Passes Key Toxicology Milestone

  March 8, 2007

   · 

  1 min read
• BioMidwest

  Ventana Medical Systems, Inc. Launches Automated HER2 Silver for Breast Cancer Pathology

  March 8, 2007

   · 

  1 min read
• Medipattern™ Corporation Launches B-CAD(TM) 1.2 at Northwestern University

  March 8, 2007

   · 

  1 min read
• Business

  Galapagos Genomics NV to Supply Chemical Compound Sets to Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V.

  March 8, 2007

   · 

  1 min read
• Business

  Anthera Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board for Respiratory and Acute Care Programs

  March 8, 2007

   · 

  6 min read
• Genetown

  Archemix Corporation is Granted Two European Patents for the Identification and Use of Therapeutic Aptamers

  March 8, 2007

   · 

  3 min read